Sign In
Buy HUM
$327.54
+6.66 (+2.08%)
At Close: Jun 03, 2026
AM Best Assigns Issue Credit Ratings to Humana Inc.'s New Senior Unsecured Notes
10:55am, Wednesday, 05'th Mar 2025
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb” (Good) to the $750 million, 5.5% senior unsecured notes, due 2035, and the $500 million,
Humana Prices $1.25 Billion Debt Offering
08:15pm, Monday, 03'rd Mar 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
04:10am, Wednesday, 26'th Feb 2025
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, res
Humana Foundation Donates $250,000 to Support Disaster Recovery in the Wake of Catastrophic Flooding in Kentucky
01:29pm, Monday, 24'th Feb 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by de
Humana Gains Despite Medicare Advantage Losses—What's the Catch?
08:45am, Thursday, 20'th Feb 2025
The medical sector giant was one of the first carriers to sound the alarm of rising inpatient utilization costs, notably with its Medicare Advantage (MA) plan members in Q4 2023.
Humana Board Declares Payment of Quarterly Dividend to Stockholders
06:30am, Thursday, 20'th Feb 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25, 2025 to stoc
Humana and Monogram Health Announce Expansion of Comprehensive Kidney Care Program
10:00am, Thursday, 13'th Feb 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Monogram Health announce expansion of comprehensive kidney care program.
Humana Q4 Earnings Review: A Tough Quarter -- And A Rating Downgrade
11:08am, Wednesday, 12'th Feb 2025
Humana Inc.'s Q4 and full-year 2024 earnings report shows a 10% revenue increase but significant losses, highlighting major structural issues in its business model. Rising healthcare utilization and i
Is Humana dropping your Medicare Advantage plan? Here's what you need to know.
04:09pm, Tuesday, 11'th Feb 2025
The cuts will mean turmoil and confusion for many beneficiaries, as well as the risk of higher premiums, fewer benefits or both.
Humana Incurs Wider Y/Y Loss in Q4 on Decline in Membership
01:56pm, Tuesday, 11'th Feb 2025
HUM's fourth-quarter results suffer a blow due to a membership decline in Medicare stand-alone PDP, partly offset by a strong Primary Care business. It currently expects 2025 adjusted EPS to be around
Humana, Inc. (HUM) Q4 2024 Earnings Call Transcript
12:48pm, Tuesday, 11'th Feb 2025
Humana, Inc. (NYSE:HUM ) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George R
Humana Stock Drops as Medicare Advantage Members Expected to Decline
11:35am, Tuesday, 11'th Feb 2025
Humana (HUM) shares slid after the health insurer said it expects Medicare Advantage memberships to decline in 2025.
Humana (HUM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Tuesday, 11'th Feb 2025
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare
NYSE: HUM Lawsuit Update: Investors who lost money with Humana Inc. (NYSE: HUM) shares should contact the Shareholders Foundation
10:25am, Tuesday, 11'th Feb 2025
SAN DIEGO , Feb. 11, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Humana Inc. (NYSE: HUM). Investors who
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
08:45am, Tuesday, 11'th Feb 2025
Humana (HUM) came out with a quarterly loss of $2.16 per share versus the Zacks Consensus Estimate of a loss of $2.26. This compares to loss of $0.11 per share a year ago.
